These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15639317)

  • 1. Alzheimer disease and Down syndrome: factors in pathogenesis.
    Lott IT; Head E
    Neurobiol Aging; 2005 Mar; 26(3):383-9. PubMed ID: 15639317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased amyloid beta protein levels in children and adolescents with Down syndrome.
    Mehta PD; Capone G; Jewell A; Freedland RL
    J Neurol Sci; 2007 Mar; 254(1-2):22-7. PubMed ID: 17275850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental origins of aging in brain and blood vessels: an overview.
    Finch CE
    Neurobiol Aging; 2005 Mar; 26(3):281-91. PubMed ID: 15639305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down syndrome and Alzheimer's disease: a link between development and aging.
    Lott IT; Head E
    Ment Retard Dev Disabil Res Rev; 2001; 7(3):172-8. PubMed ID: 11553933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced short latency afferent inhibition in patients with Down syndrome and Alzheimer-type dementia.
    Nardone R; Marth R; Ausserer H; Bratti A; Tezzon F
    Clin Neurophysiol; 2006 Oct; 117(10):2204-10. PubMed ID: 16931146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
    Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased serum neopterin levels in adults with Down syndrome.
    Mehta PD; Patrick BA; Dalton AJ; Patel B; Mehta SP; Pirttila T; Coyle PK
    J Neuroimmunol; 2005 Jul; 164(1-2):129-33. PubMed ID: 15908015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down syndrome, Alzheimer's disease and seizures.
    Menéndez M
    Brain Dev; 2005 Jun; 27(4):246-52. PubMed ID: 15862185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total serum cholesterol levels and Alzheimer's dementia in patients with Down syndrome.
    Prasher VP; Airuehia E; Patel A; Haque MS
    Int J Geriatr Psychiatry; 2008 Sep; 23(9):937-42. PubMed ID: 18395888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease.
    Donahue JE; Johanson CE
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):261-70. PubMed ID: 18379441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid beta concentrations in older people with Down syndrome and dementia.
    Jones EL; Hanney M; Francis PT; Ballard CG
    Neurosci Lett; 2009 Feb; 451(2):162-4. PubMed ID: 19111900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E, amyloid, and Alzheimer disease.
    Bales KR; Dodart JC; DeMattos RB; Holtzman DM; Paul SM
    Mol Interv; 2002 Oct; 2(6):363-75, 339. PubMed ID: 14993413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E.
    Fan J; Donkin J; Wellington C
    Biofactors; 2009; 35(3):239-48. PubMed ID: 19472365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral small vessel disease-induced apolipoprotein E leakage is associated with Alzheimer disease and the accumulation of amyloid beta-protein in perivascular astrocytes.
    Utter S; Tamboli IY; Walter J; Upadhaya AR; Birkenmeier G; Pietrzik CU; Ghebremedhin E; Thal DR
    J Neuropathol Exp Neurol; 2008 Sep; 67(9):842-56. PubMed ID: 18716559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality is associated with apolipoprotein E epsilon4 in nondemented adults with Down syndrome.
    Zigman WB; Jenkins EC; Tycko B; Schupf N; Silverman W
    Neurosci Lett; 2005 Dec; 390(2):93-7. PubMed ID: 16122874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation, genes and zinc in Alzheimer's disease.
    Vasto S; Candore G; Listì F; Balistreri CR; Colonna-Romano G; Malavolta M; Lio D; Nuzzo D; Mocchegiani E; Di Bona D; Caruso C
    Brain Res Rev; 2008 Jun; 58(1):96-105. PubMed ID: 18190968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current insights into molecular mechanisms of Alzheimer disease and their implications for therapeutic approaches.
    Van Broeck B; Van Broeckhoven C; Kumar-Singh S
    Neurodegener Dis; 2007; 4(5):349-65. PubMed ID: 17622778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E and Alzheimer disease.
    Huang Y
    Neurology; 2006 Jan; 66(2 Suppl 1):S79-85. PubMed ID: 16432152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.
    Roy S; Rauk A
    Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease pathogenesis: role of aging.
    Harman D
    Ann N Y Acad Sci; 2006 May; 1067():454-60. PubMed ID: 16804026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.